The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Promising Clinical Results For Takeda’s Dengue Vaccine
Takeda’s dengue vaccine candidate TAK-003 has been shown to provide protection against all four serotypes of the virus for at least 18 months.
Simulating The Flow Of Supercooled Water
Using highly accurate computer simulations, scientists in Japan have characterized the diffusion and viscosity behavior of supercooled water.
Metals Show How Liquids Turn Into Glass
By cooling an organic metal material at different rates, scientists in Japan have gained a better understanding of how liquids turn into glass.
High Blood Pressure In China Spiraling Out Of Control
More and more people in China are suffering from high blood pressure, but proper medication to manage the disease is often lacking.
Room To Grow The Grid
Although both formats have their merits, cul-de-sac-dominated Singapore could benefit from more grid roads like those in New York City, says SMU Associate Professor Hsu Wen-Tai.
Predictor Of Deadly Cancer Common In Asia Discovered
Researchers have identified a novel prognostic indicator in one of the most common malignant tumors in southern China and Southeast Asia.
Asia’s Rising Scientists: Nethia Mohana Kumaran
Dr. Nethia Mohana Kumaran dreams of a future where cancer is treated according to its mutations, using targeted therapy rather than a ‘one-size-fits-all’ strategy.
Smoking Increases Risk Of Nasopharyngeal Cancer Relapse
Survivors of nasopharyngeal carcinoma who are former or current smokers are more likely to have their disease progress, relapse, or spread, according to a study.
Tessa Therapeutics Completes Acquisition of Euchloe Bio
Tessa Therapeutics has fully acquired Euchloe Bio, a biotech company focused on developing and commercializing therapeutic antibodies.